← Open Payments lookup

TOMMI ALCORN: Open Payments

NPI 1538717871 · HOUSTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 34 payments from 17 companies in 2025. Trend: 2023 $446 · 2024 $394 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.5$133
Novo Nordisk Inc4$77
Verona Pharma, Inc.3$69
Otsuka America Pharmaceutical, Inc.3$63
Baxter Healthcare1$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
AstraZeneca Pharmaceuticals LP3$44
GENZYME CORPORATION2$44
Insulet Corporation2$41
Grifols USA, LLC2$33

Products named: DUPIXENT, REXULTI, Ohtuvayre, Hillrom - Vest System Model 205 Acute Care, CAPLYTA, Omnipod, Wegovy, Prolastin-C Liquid.

Industry payments across MO — which companies pay providers there.